Abstract
Eculizumab Treatment Outcomes in Patients with Allogeneic Hematopoietic Cell Transplant (alloHCT)-Associated Thrombotic Microangiopathy (TA-TMA): A Retrospective Single-Center Experience
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have